Research location
Minsk
Belarus
Advertisement
Research activity in Minsk
BelarusCureCurrent currently publishes aggregate city-level research activity for this location: 88 trials and 147 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Minsk
88 linked trials · page 1 of 2BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast CancerNCT07108309 · 2024-07-15 · 1 site observation
RECRUITING
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionNCT05179876 · 2022-05-04 · 2 site observations
RECRUITING
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin MelanomaNCT05751928 · 2023-04-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic MelanomaNCT05732805 · 2022-08-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisNCT05269004 · 2022-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic CellsNCT05207995 · 2022-03-01 · 1 site observation
COMPLETED
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass DeviceNCT05145894 · 2021-09-30 · 1 site observation
UNKNOWN
A Study of Selexipag in Participants Who Participated in a Previous Selexipag StudyNCT04565990 · 2021-05-03 · 2 site observations
COMPLETED
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF StudyNCT04331769 · 2020-12-21 · 1 site observation
SUSPENDED
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)NCT04497844 · 2020-09-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · 2020-07-02 · 1 site observation
TERMINATED
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial HypertensionNCT04273945 · 2020-06-30 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial HypertensionNCT04175600 · 2020-01-16 · 2 site observations
ACTIVE_NOT_RECRUITING
An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisNCT04130997 · 2019-11-18 · 3 site observations
ACTIVE_NOT_RECRUITING
Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®NCT04115488 · 2019-10-01 · 3 site observations
COMPLETED
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMSNCT04121221 · 2019-09-19 · 3 site observations
COMPLETED
Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03NCT04109391 · 2019-08-20 · 1 site observation
COMPLETED
Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast CancerNCT04588935 · 2019-07-01 · 1 site observation
COMPLETED
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerNCT03871816 · 2019-04-22 · 1 site observation
COMPLETED
Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU StudyNCT03183895 · 2019-01-15 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of ZN-c5 in Subjects With Breast CancerNCT03560531 · 2018-11-30 · 1 site observation
COMPLETED
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast CancerNCT03433313 · 2018-10-16 · 1 site observation
COMPLETED
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial HypertensionNCT03492177 · 2018-07-23 · 2 site observations
ACTIVE_NOT_RECRUITING
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel AgentsNCT03619252 · 2018-07-01 · 1 site observation
COMPLETED
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast CancerNCT03556358 · 2018-06-28 · 1 site observation
COMPLETED
A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.NCT03422328 · 2018-04-05 · 1 site observation
COMPLETED
A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer PatientsNCT03013504 · 2018-02-19 · 1 site observation
COMPLETED
The BCD-089 (aIL6R) in Patients With Active Rheumatoid ArthritisNCT03455842 · 2018-02-01 · 1 site observation
COMPLETED
A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MSNCT03290131 · 2018-01-28 · 3 site observations
COMPLETED
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple SclerosisNCT03232073 · 2017-07-05 · 2 site observations
COMPLETED
Parkinson's Disease Therapy Using Cell TechnologyNCT04146519 · 2017-07-01 · 1 site observation
UNKNOWN
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT03088540 · 2017-05-29 · 1 site observation
COMPLETED
MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLCNCT04633564 · 2017-01-21 · 1 site observation
COMPLETED
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung CancerNCT02754882 · 2016-07-05 · 1 site observation
COMPLETED
Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseaseNCT02760368 · 2016-05-19 · 1 site observation
COMPLETED
TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)NCT02676089 · 2016-04-06 · 3 site observations
COMPLETED
A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateNCT02706873 · 2016-02-23 · 2 site observations
COMPLETED
Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid ArthritisNCT02762838 · 2016-01-01 · 3 site observations
COMPLETED
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to MethotrexateNCT02629159 · 2015-12-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple SclerosisNCT02576717 · 2015-10-16 · 3 site observations
COMPLETED
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic AsthmaNCT02596321 · 2015-10-01 · 2 site observations
COMPLETED
Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisNCT02425644 · 2015-06-04 · 2 site observations
COMPLETED
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)NCT02294058 · 2014-12-03 · 3 site observations
COMPLETED
Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerNCT02200614 · 2014-09-12 · 1 site observation
COMPLETED
A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual AdministrationNCT02194166 · 2014-07-18 · 1 site observation
COMPLETED
Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast CancerNCT02162667 · 2014-06-01 · 2 site observations
COMPLETED
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerNCT02111577 · 2014-05-26 · 1 site observation
COMPLETED
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)NCT02115750 · 2014-05-01 · 2 site observations
COMPLETED
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerNCT02163694 · 2014-04-08 · 1 site observation
COMPLETED
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.